EyePoint Pharmaceuticals, Inc. revenue breakdown overview

EyePoint Pharmaceuticals, Inc. revenue for the last year amounted to 46.00 M USD, the most of which — 30.80 M USD — came from its highest performing source at the moment, License and Collaboration Agreements, the year earlier bringing 362.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought EyePoint Pharmaceuticals, Inc. 45.27 M USD, and the year before that — 40.48 M USD.